The FDA has even accredited a drug produced with cannabidiol for that goal (Epidiolex). However the agency only recommends it for 2 exceptional types of childhood epilepsy named Lennox-Gastaut syndrome and Dravet syndrome.Working with these products at a youthful age specifically increases the chance of acquiring a cannabis use dysfunction afterwar